[1]
“ Levels of Circulating Monocytes-An Indicator for Cardiovascular complications in Type 2 Diabetes”, ijop, vol. 7, no. 1, pp. 55–59, Apr. 2019, doi: 10.37506/ijop.v7i1.265.